With respect to Alu elements, mitochondrial dysfunction, and the broader pathological scope of AD and other neurodegenerative diseases, there is evidence suggesting that Alu-derived peptides interact with tau proteins, perhaps serving a regulatory role for tau phosphorylation (Hoenicka et al. 2002). Here, MAPT is linked to Alzheimer disease.